A novel VIM-type metallo-beta-lactamase (VIM-14) in a Pseudomonas aeruginosa clinical isolate from a neonatal

A Mazzariol1, C Mammina, R Koncan

  • 1Dipartimento di Patologia e Diagnostica, Università di Verona, Verona, Italy. annarita.mazzariol@univr.it

Insights

A new carbapenem-resistant Pseudomonas aeruginosa strain was found in Italy. It carries a novel VIM-14 enzyme, a carbapenemase, within a unique class 1 integron.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen.
  • Carbapenem resistance is a significant global health threat.
  • Neonatal intensive care units are vulnerable to multidrug-resistant organism outbreaks.

Purpose of the Study:

  • To characterize a novel carbapenem-resistant Pseudomonas aeruginosa isolate.
  • To identify the genetic mechanisms conferring carbapenem resistance.
  • To investigate the genetic environment of the resistance genes.

Main Methods:

  • Bacterial isolation and identification.
  • Antimicrobial susceptibility testing.
  • Whole-genome sequencing.
  • Plasmid analysis.
  • Gene sequencing and characterization of resistance determinants.

Main Results:

  • A Pseudomonas aeruginosa strain highly resistant to carbapenems was isolated from a neonatal intensive care unit.
  • The strain harbored a novel VIM-type carbapenemase, designated VIM-14.
  • VIM-14 differs from VIM-4 by a single amino acid substitution (G31S).
  • The blaVIM-14 gene was located within a class 1 integron with a novel gene cassette arrangement (aacA7-blaVIM-14-blaOXA-20-aacC4).

Conclusions:

  • A new carbapenem resistance mechanism mediated by VIM-14 has emerged in Pseudomonas aeruginosa.
  • The novel integron structure may facilitate the spread of carbapenem resistance.
  • This finding highlights the need for enhanced surveillance of carbapenem-resistant bacteria in healthcare settings.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...